Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).

被引：0
作者：
Martini, Dylan J.
Shabto, Julie M.
Liu, Yuan
Carthon, Bradley Curtis
Speak, Alexandra
Hitron, Elise
Russler, Greta
Caulfield, Sarah
Ogan, Kenneth
Harris, Wayne
Master, Viraj A.
Kucuk, Omer
Bilen, Mehmet Asim
机构：
[1] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA
[2] Emory Univ, Dept Biostat, Atlanta, GA 30322 USA
[3] Emory Univ, Dept Bioinformat, Atlanta, GA 30322 USA
[4] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA
[5] Emory Univ, Sch Med, Dept Pharmaceut Serv, Atlanta, GA USA
[6] Emory Univ, Sch Med, Dept Urol, Atlanta, GA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：2
相关论文
共 50 条
[21]   CABOPRE: A phase II study of cabozantinib (cabo) prior cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC) [J].
De Velasco, G. ;
Alonso-Gordoa, T. ;
Rodriguez-Moreno, J. F. ;
Duran, I. ;
Carretero-Gonzalez, A. ;
Martin-Soberon, M. ;
Gutierrez Banos, J. L. ;
Guerrero-Ramos, F. ;
Duenas, M. ;
Castellano Gauna, D. .
ANNALS OF ONCOLOGY, 2021, 32 :S698-S699
[22]   Predictors of progressive disease (PD) and subsequent outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) [J].
Zahoor, Haris ;
Barata, Pedro C. ;
Jia, Xuefei ;
Hobbs, Brian P. ;
Martin, Allison ;
Allman, Kimberly D. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[23]   Tumor response is an independent prognostic factor in patients (pts) treated for metastatic renal cell carcinoma (mRCC) [J].
Gruenwald, V. ;
Lin, X. ;
Kalanovic, D. ;
McKay, R. ;
Perkins, J. ;
Simantov, R. ;
Choueiri, T. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 :S642-S642
[24]   Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)? [J].
Keizman, Daniel ;
Ish-Shalom, Maya ;
Maimon, Natalie ;
Gottfried, Maya ;
Pili, Roberto ;
Hammers, Hans J. ;
Eisenberger, Mario A. ;
Sinibaldi, Victoria J. ;
Boursi, Ben ;
Weitzen, Rony ;
Hayat, Henry ;
Peer, Avivit ;
Neumann, Avivit ;
Kovel, Svetlana ;
Sella, Avishay ;
Mermershtain, Wilmosh ;
Rouvinov, Keren ;
Berger, Raanan ;
Carducci, Michael Anthony .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[25]   Efficacy and safety of sunitinib (SU) in patients (pts) with metastatic renal cell carcinoma (mRCC) and lung metastases (mets) only at baseline [J].
Shinohara, Nobuo ;
Akaza, Hideyuki ;
Tomita, Yoshihiko ;
Yuasa, Takeshi ;
Fujimoto, Hiroyuki ;
Niwakawa, Masashi ;
Ozono, Seiichiro ;
Mugiya, Soichi ;
Miki, Tsuneharu ;
Uemura, Hirotsugu ;
Nonomura, Norio ;
Takahashi, Masayuki ;
Hasegawa, Yoshihiro ;
Ueda, Eiji ;
Shibata, Atsushi ;
Kawai, Norisuke ;
Naito, Seiji .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[26]   Combination cabozantinib and nivolumab treatment in patients with refractory metastatic renal cell carcinoma (mRCC) [J].
Kinsey, Emily ;
Brown, Landon ;
Kao, Chester ;
Healy, Patrick ;
Harrison, Michael ;
McNamara, Megan ;
Armstrong, Andrew ;
Ramalingham, Sundhar ;
George, Daniel ;
Zhang, Tian .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
[27]   Are there geographic differences in the outcome of patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib (su)? [J].
Keizman, Daniel ;
Ish-Shalom, Maya ;
Maimon, Natalie ;
Gottfried, Maya ;
Pili, Roberto ;
Hammers, Hans J. ;
Eisenberger, Mario A. ;
Sinibaldi, Victoria J. ;
Boursi, Ben ;
Weitzen, Rony ;
Hayat, Henry ;
Peer, Avivit ;
Neumann, Avivit ;
Kovel, Svetlana ;
Sella, Avishay ;
Mermershtain, Wilmosh ;
Roubinov, Keren ;
Berger, Raanan ;
Carducci, Michael Anthony .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[28]   Outcomes of sunitinib therapy in patients (pts) with metastatic renal cell carcinoma (mRCC) with poor risk features [J].
Barroso-Sousa, Romualdo ;
Munhoz, Rodrigo Ramella ;
Fonseca, Leonardo Gomes ;
de Sousa Fede, Angelo Bezerra ;
Marques Linck, Rudinei Diogo ;
Venchiarutti Moniz, Camila Motta ;
Mak, Milena Perez ;
Souza, Ciro Eduardo ;
Hoff, Paulo M. ;
Dzik, Carlos .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[29]   Active surveillance (AS) in the management of patients (pts) with metastatic renal cell carcinoma (mRCC). [J].
Ivanyi, Philipp ;
Eggers, Hendik ;
Seidel, Christoph Alexander ;
Reuter, Christoph ;
Ganser, Arnold ;
Gruenwald, Viktor .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[30]   Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab [J].
Brown, Landon C. ;
Desai, Kunal ;
Wei, Wei ;
Kinsey, Emily N. ;
Kao, Chester ;
George, Daniel J. ;
Rini, Brian, I ;
Ornstein, Moshe C. ;
Zhang, Tian .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
12345